Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis
- PMID: 6204037
- DOI: 10.1002/jps.2600730617
Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis
Abstract
The effects of drug stability, radioactive tracer purity, buffer composition, protein concentration, and fluid shifts on the nonlinear plasma protein binding of prednisolone were examined by equilibrium dialysis. Prednisolone exhibits a concentration-dependent degradation; however, the limited extent of this does not affect protein binding. Impure tritiated prednisolone used as a tracer produces incorrect, low fractional binding values with the binding parameters generated for transcortin affected more than those for albumin. Isotonic sodium phosphate and Krebs original Ringer phosphate buffers yield similar fractional binding of prednisolone and identical protein binding parameters. Fractional binding of the steroid decreases with total plasma protein concentration, but the association constants remain constant over a twofold dilution of plasma proteins. Further dilution increases these parameters. A time-dependent colloidal osmotic fluid shift during dialysis causes dilution of plasma protein concentrations and diminished drug binding. Theoretical simulations show that the osmotic fluid shifts produce the largest changes in fractional binding for compounds that are bound by low-capacity proteins with low association constants (K less than 10(6) M-1). A mathematical equation was developed to correct bound drug concentrations and fraction bound for protein dilution caused by this effect. The fluid shifts can be prevented by the addition of dextran (mol. wt. 70,000) to the dialysis buffer in a concentration of 55% of the total protein concentration. Multiple factors can diminish the nonlinear prednisolone binding as artifacts during equilibrium dialysis, but the changes are relatively modest.
Similar articles
-
Volume shifts and protein binding estimates using equilibrium dialysis: application to prednisolone binding in humans.J Pharm Sci. 1983 Dec;72(12):1442-6. doi: 10.1002/jps.2600721218. J Pharm Sci. 1983. PMID: 6663482
-
The effect of prednisone and hydrocortisone on the plasma protein binding of prednisolone in man.Eur J Clin Pharmacol. 1986;30(1):51-5. doi: 10.1007/BF00614195. Eur J Clin Pharmacol. 1986. PMID: 3709632
-
Nonlinear plasma protein binding and haemodialysis clearance of prednisolone.Eur J Clin Pharmacol. 1982;23(1):65-74. doi: 10.1007/BF01061379. Eur J Clin Pharmacol. 1982. PMID: 6751835
-
Errors in interpretation of data from equilibrium dialysis protein binding experiments.Res Commun Chem Pathol Pharmacol. 1979 Oct;26(1):145-60. Res Commun Chem Pathol Pharmacol. 1979. PMID: 515500
-
Plasma protein binding interaction of prednisone and prednisolone.J Steroid Biochem. 1984 Sep;21(3):337-9. doi: 10.1016/0022-4731(84)90288-7. J Steroid Biochem. 1984. PMID: 6492791
Cited by
-
Predictions of the in vivo clearance of drugs from rate of loss using human liver microsomes for phase I and phase II biotransformations.Pharm Res. 2006 Apr;23(4):654-62. doi: 10.1007/s11095-006-9663-4. Epub 2006 Mar 24. Pharm Res. 2006. PMID: 16550474
-
Measurement and analysis of unbound drug concentrations.Clin Pharmacokinet. 1996 Jun;30(6):445-62. doi: 10.2165/00003088-199630060-00003. Clin Pharmacokinet. 1996. PMID: 8792057 Review.
-
Surgical management of peritoneal metastasis: Opportunities for pharmaceutical research.J Control Release. 2023 Sep;361:717-726. doi: 10.1016/j.jconrel.2023.08.017. Epub 2023 Aug 22. J Control Release. 2023. PMID: 37574051 Free PMC article.
-
Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys.Antimicrob Agents Chemother. 1996 Mar;40(3):561-6. doi: 10.1128/AAC.40.3.561. Antimicrob Agents Chemother. 1996. PMID: 8851571 Free PMC article.
-
Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.J Pharmacokinet Biopharm. 1998 Jun;26(3):289-317. doi: 10.1023/a:1023233409550. J Pharmacokinet Biopharm. 1998. PMID: 10098101
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials